EUVIMEDEUVIMED entdecken
Crossref

GSTM2 as the molecular linking of depression-driven colon cancer progression and chemoresistance: Reversal by Sinisan

Na Li, Keying Chen, Bin Nie, Fangjun Yu, Anni Ren, Shuquan Yang, Jinlan Zhao, Yanwu Li, Lingling Yang, Shuting Wen, Ying Tang, Pei Xie und 5 weitere

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Na Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: School of Fundamental Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Depression, Glutathione Transferase, Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Province, Fundo para o Desenvolvimento das Ciências e da Tecnologia, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Depression has emerged as a concerning factor in colon cancer progression and treatment, yet its underlying mechanisms and therapeutic targets remain poorly defined. PURPOSE: This study aimed to elucidate how depression affects colon cancer progression and chemotherapeutic response, and to explore potential molecular targets and therapeutic interventions involving the traditional Chinese medicine formula Sinisan (SNS) and its bioactive component Quercetin. STUDY DESIGN AND METHODS: A mouse model combining depression and colon cancer was established to evaluate behavioral alterations, tumor progression, and pathological features. RNA sequencing was performed to screen the differentially expressed genes. The effects of corticosterone (CORT) on proliferation, colony formation, migration, and GSTM2 expression were examined in HCT116 cells, followed by functional validation through GSTM2 overexpression and inhibition assays. Molecular docking, molecular dynamics simulations, and surface plasmon resonance (SPR) were used to validate the binding of Quercetin to GSTM2. The therapeutic efficacy of SNS and Quercetin was assessed with respect to depressive symptoms, serum BDNF levels, NLRP3 inflammasome activity, and the potency of 5-fluorouracil (5-FU) chemotherapy. RESULTS: Mice with depression and colon cancer exhibited aggravated depressive behaviors and accelerated tumor progression. RNA-sequencing and network pharmacology analyses identified GSTM2 as a promising candidate target in colon cancer treatment, which was markedly down-regulated in the DP-CC group. CORT enhanced proliferation, colony formation, and migration of HCT116 cells while simultaneously suppressing GSTM2 expression. Conversely, GSTM2 levels negatively correlated with cell proliferation, colony formation, and chemoresistance in HCT116 cells. Treatment with SNS alleviated depressive symptoms, elevated serum BDNF, reduced NLRP3 inflammasome activity, and potentiated the efficacy of 5-FU chemotherapy. Quercetin, a bioactive component of SNS, bound to GSTM2 through hydrogen-bond and van-der-Waals interactions, up-regulated GSTM2 expression, and mitigated CORT-induced proliferation, colony formation, and chemoresistance. CONCLUSION: Our findings suggest that depression promotes colon-cancer progression by down-regulating GSTM2, whereas SNS restores GSTM2 expression and enhances chemotherapeutic response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsDepressionGlutathione TransferaseDrugs, Chinese HerbalAnimalsHumansMiceQuercetinDrug Resistance, NeoplasmMolecular Docking SimulationMaleCell ProliferationHCT116 CellsDisease ProgressionFluorouracilCorticosterone

Stichwörter der Autor:innen

ChemotherapyColon cancerDepressionGSTM2Sinisan

Substanzen

QuercetinGlutathione TransferaseFluorouracilDrugs, Chinese HerbalCorticosterone

Autor:innen und Institutionen

  • School of Fundamental Medical Science, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
  • Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
  • Acupuncture Rehabilitation Department, Guangdong Provincial Second Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong Province, China; Guangdong Provincial Key Laboratory of Research and Development in Tradi…
  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China.
  • Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, and The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, Chin…
  • Nam Yue Natural Medicine Co., Ltd., Macau, China.

Förderung

  • Natural Science Foundation of Guangxi Province
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, N., Chen, K., Nie, B., Yu, F., Ren, A., Yang, S., Zhao, J., Li, Y., Yang, L., Wen, S., Tang, Y., Xie, P., Zhang, R., Pan, H., Wang, Z., Liu, N., & Shi, Y. (2026). GSTM2 as the molecular linking of depression-driven colon cancer progression and chemoresistance: Reversal by Sinisan. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158113

Vancouver

Li N, Chen K, Nie B, Yu F, Ren A, Yang S, et al. GSTM2 as the molecular linking of depression-driven colon cancer progression and chemoresistance: Reversal by Sinisan. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158113

BibTeX
@article{Li2026,
  author = {Li, Na and Chen, Keying and Nie, Bin and Yu, Fangjun and Ren, Anni and Yang, Shuquan and Zhao, Jinlan and Li, Yanwu and Yang, Lingling and Wen, Shuting and Tang, Ying and Xie, Pei and Zhang, Rong and Pan, Huafeng and Wang, Zhiyu and Liu, Naihua and Shi, Yafei},
  title = {GSTM2 as the molecular linking of depression-driven colon cancer progression and chemoresistance: Reversal by Sinisan},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158113}
}
Kostenlos starten →